Clinical Utility of Germline Whole-Exome Sequencing Beyond Multigene Panels in Hereditary Cancer
This review critically examines the current evidence supporting the clinical utility of germline WES in Hereditary Cancer syndromes, focusing on the clinical scenarios in which WES may provide meaningful additional information beyond multigene panels, its diagnostic yield, limitations, and future perspectives in precis...